Approval · Notice of Compliance 20121 · 2017
DICETEL: Notice of Compliance 20121
Issued December 1, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20121
- Date
- December 1, 2017
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug substance supplier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DICETEL | Not yet assigned | — |
Medicinal ingredients
- PINAVERIUM BROMIDE 50 MG per TAB
- PINAVERIUM BROMIDE 100 MG per TAB